Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

1.

Hepatitis B virus (HBV) status of children born to HIV/HBV co-infected women in a French hospital: a cross-sectional study.

Sellier P, Schnepf N, Amarsy R, Maylin S, Coutellier M, Lopes A, Mazeron MC, Flateau C, Morgand M, Ciraru-Vigneron N, Berthe A, Ricbourg A, Dolores-Moreno AM, Simoneau G, Evans J, Souak S, Matheron S, Mouly S, Benifla JL, Simon F, Bergmann JF.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19632. doi: 10.7448/IAS.17.4.19632. eCollection 2014.

PMID:
25394136
[PubMed - in process]
Free PMC Article
2.

French 2013 guidelines for antiretroviral therapy of HIV-1 infection in adults.

Hoen B, Bonnet F, Delaugerre C, Delobel P, Goujard C, L'Hénaff M, Persiaux R, Rey D, Rouzioux C, Taburet AM, Morlat P; 2013 French HIV expert group.

J Int AIDS Soc. 2014 Jun 17;17:19034. doi: 10.7448/IAS.17.1.19034. eCollection 2014.

PMID:
24942364
[PubMed - indexed for MEDLINE]
Free PMC Article
3.
4.

Effectiveness and cost effectiveness of oral pre-exposure prophylaxis in a portfolio of prevention programs for injection drug users in mixed HIV epidemics.

Alistar SS, Owens DK, Brandeau ML.

PLoS One. 2014 Jan 28;9(1):e86584. doi: 10.1371/journal.pone.0086584. eCollection 2014.

PMID:
24489747
[PubMed - in process]
Free PMC Article
5.

The acceptability and feasibility of an HIV preexposure prophylaxis (PrEP) trial with young men who have sex with men.

Hosek SG, Siberry G, Bell M, Lally M, Kapogiannis B, Green K, Fernandez MI, Rutledge B, Martinez J, Garofalo R, Wilson CM; Adolescent Trials Network for HIVAIDS Interventions (ATN).

J Acquir Immune Defic Syndr. 2013 Apr 1;62(4):447-56. doi: 10.1097/QAI.0b013e3182801081.

PMID:
24135734
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Safety, adherence and acceptability of intermittent tenofovir/emtricitabine as HIV pre-exposure prophylaxis (PrEP) among HIV-uninfected Ugandan volunteers living in HIV-serodiscordant relationships: a randomized, clinical trial.

Kibengo FM, Ruzagira E, Katende D, Bwanika AN, Bahemuka U, Haberer JE, Bangsberg DR, Barin B, Rooney JF, Mark D, Chetty P, Fast P, Kamali A, Priddy FH.

PLoS One. 2013 Sep 26;8(9):e74314. doi: 10.1371/journal.pone.0074314. eCollection 2013.

PMID:
24086333
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Knowledge of and opinions on HIV preexposure prophylaxis among front-line service providers at Canadian AIDS service organizations.

Senn H, Wilton J, Sharma M, Fowler S, Tan DH.

AIDS Res Hum Retroviruses. 2013 Sep;29(9):1183-9. doi: 10.1089/AID.2013.0090. Epub 2013 Jun 22.

PMID:
23731254
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Is tenofovir/emtricitabine teratogenic?

Jibril M, Egunsola O.

Ther Adv Drug Saf. 2013 Jun;4(3):115-7. doi: 10.1177/2042098613485276.

PMID:
25083255
[PubMed]
Free PMC Article
9.

Oral antiretroviral drugs as public health tools for HIV prevention: global implications for adherence, drug resistance, and the success of HIV treatment programs.

Gupta RK, Wainberg MA, Brun-Vezinet F, Gatell JM, Albert J, Sönnerborg A, Nachega JB.

J Infect Dis. 2013 Jun 15;207 Suppl 2:S101-6. doi: 10.1093/infdis/jit108.

PMID:
23687287
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Greater suppression of nevirapine resistance with 21- vs 7-day antiretroviral regimens after intrapartum single-dose nevirapine for prevention of mother-to-child transmission of HIV.

McMahon DK, Zheng L, Hitti J, Chan ES, Halvas EK, Hong F, Kabanda J, Taulo F, Kumarasamy N, Bonhomme J, Wallis CL, Klingman KL, Hughes MD, Mellors JW.

Clin Infect Dis. 2013 Apr;56(7):1044-51. doi: 10.1093/cid/cis1219. Epub 2013 Jan 8.

PMID:
23300238
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

A novel combination HIV prevention strategy: post-exposure prophylaxis with contingency management for substance abuse treatment among methamphetamine-using men who have sex with men.

Landovitz RJ, Fletcher JB, Inzhakova G, Lake JE, Shoptaw S, Reback CJ.

AIDS Patient Care STDS. 2012 Jun;26(6):320-8. doi: 10.1089/apc.2011.0432.

PMID:
22680280
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Nephrotoxicity of HAART.

Kalyesubula R, Perazella MA.

AIDS Res Treat. 2011;2011:562790. doi: 10.1155/2011/562790. Epub 2011 Aug 15.

PMID:
21860787
[PubMed]
Free PMC Article
13.

Very high concentrations of active intracellular phosphorylated emtricitabine in neonates (ANRS 12109 trial, step 2).

Hirt D, Pruvost A, Ekouévi DK, Urien S, Arrivé E, Kone M, Nerrienet E, Nyati M, Gray G, Kruy LS, Blanche S, Dabis F, Tréluyer JM.

Antimicrob Agents Chemother. 2011 Jun;55(6):2953-60. doi: 10.1128/AAC.01376-10. Epub 2011 Apr 4.

PMID:
21464241
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

CD4+ cell count and risk for antiretroviral drug resistance among women using peripartum nevirapine for perinatal HIV prevention.

Dorton BJ, Mulindwa J, Li MS, Chintu NT, Chibwesha CJ, Mbewe F, Frenkel LM, Stringer JS, Chi BH.

BJOG. 2011 Mar;118(4):495-9. doi: 10.1111/j.1471-0528.2010.02835.x. Epub 2010 Dec 24.

PMID:
21199294
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Intrapartum tenofovir and emtricitabine reduces low-concentration drug resistance selected by single-dose nevirapine for perinatal HIV prevention.

Chi BH, Ellis GM, Chintu N, Cantrell RA, Sinkala M, Aldrovandi GM, Warrier R, Mbewe F, Nakamura K, Stringer EM, Frenkel LM, Stringer JS.

AIDS Res Hum Retroviruses. 2009 Nov;25(11):1099-106. doi: 10.1089/aid.2009.0088.

PMID:
19886836
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk